One example among many is given by the serum prostate-specific antigen (PSA), which has been used for screening men with an existing diagnosis of prostate cancer (PCa) and is used as a marker for identifying recurring disease subsequent to treatment. Here, KLK3 is linked to posterior cortical atrophy.